Population
Patients with acute coronary syndromes and/or who are undergoing percutaneous coronary intervention
Design
Review
Authors
Loading...
Clopidogrel response variability may affect antiplatelet efficacy; leaves open the need for standardized P2Y12 assays to determine clinical prevalence.
Clopidogrel resistance is a multifactorial phenomenon that requires standardized, selective P2Y12 receptor inhibition assays to accurately determine its true clinical prevalence and impact.
Werkum et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: